Oat products and their current status in the celiac diet

Gluten-Free Cereal Products and Beverages

Volumn , Issue , 2008, Pages 191-202

  Sontag Strohm, Tuula ^a   Lehtinen, Pekka ^b   Kaukovirta Norja, Anu ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 73549097933     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012373739-7.50010-1     Document Type: Chapter

References (41)

1. Baker P.G., Read A.E. Oats and barley toxicity in celiac patients. Postgrad Med. J. 1976, 52:264-268.
2. Brown C.M., Craddock J.C. Oil content and groat weight of entries in the world oat collection. Crop Sci. 1972, 12:514-515.
3. Chronakis I.S., Öste Triantafyllou A., Öste R. Solid-state characteristics and redispersible properties of powders formed by spray-drying and freeze-drying cereal dispersions of varying (1→3,1→4)β-glucan content. J. Cereal Sci. 2004, 40:183-193.
4. Report of the 25th Session of the Codex Committee on Nutrition and Foods for Special Uses 2003, Codex Alimentarius Commission.
5. Report of the 26th Session of the Codex Committee on Methods of Analysis and Sampling 2005, Codex Alimentarius Commission.
6. Dissanayake A.S., Truelove S.C., Whitehead R. Lack of harmful effect of oats on small-intestinal mucosa in celiac disease. BMJ 1974, 4:189-191.
7. Flander L., Salmenkallio-Marttila M., Suortti T., Autio K. Optimization of ingredients and baking process for improved wholemeal oat bread quality. Lebensm. Wiss. Technol. 2007, 40:860-870.
8. Garsed K., Scott B.B. Can oats be taken in a gluten-free diet? A systematic review. Scand. J. Gastroenterol. 2007, 42:171-178.
9. Hardman C.M., Garioch J.J., Leonard J.N., Thomas H.J.W., Walker M.M., Lortan J.E. Absence of toxicity of oats in patients with dermatitis herpetiformis. N. Engl. J. Med. 1997, 337:1884-1887.
10. Hardman C., Fry L., Tatham A., Thomas H.J.W. Absence of toxicity of avenin in patients with dermatitis herpetiformis. N.Engl. J. Med. 1999, 340:321.
11. Hill A.S., Skerrit J.H. Hybridoma cells and monoclonal antibodies 1989, Patent number GB2207921 (CA1294903).
12. Hoffenberg E.J., Haas J., Drescher A., Barnburst R., Osberg I., Bao F. A trial of oats in children with newly diagnosed celiac disease. J. Pediatr. 2000, 137:361-366.
13. Hogberg L., Laurin P., Falth-Magnusson K., Grant C., Grodzinsky E., Jansson G. Oats to children with newly diagnosed coeliac disease: a randomised double blind study. Gut 2004, 53:649-654.
14. Holm K., Maki M., Vuolteenaho N. Oats in the treatment of childhood coeliac disease: a 2-year controlled trial and a long-term clinical follow-up study. Aliment. Pharmacol. Ther. 2006, 23:1463-1472.
15. Janatuinen E.K., Pikkarainen P.H., Kemppainen T.A., Kosma V.-M., Jarvinen R.M.K., Uusitupa M.I.J. A comparison of diets with and without oats in adults with celiac disease. N.Engl. J. Med. 1995, 333:1033-1037.
16. Janatuinen E.K., Kemppainen T.A., Pikkarainen P.H., Holm K.H., Kosma V.-M., Uusitupa M.I.J. Lack of cellular and humoral immunological responses to oats in adults with coeliac disease. Gut 2000, 46:327-331.
17. Janatuinen E.K., Kemppainen T.A., Julkunen R.J.K., Kosma V.-M., Maki M., Heikkinen M. No harm from five-year ingestion of oats in coeliac disease. Gut 2002, 50:332-335.
18. Kanerva P., Sontag-Strohm T., Ryöppy P., Alho-Lehto P., ja Salovaara H. Analysis of barley contamination in oats using R5 and o-gliadin antibodies. J. Cereal Sci. 2006, 44:347-352.
19. Kasarda D.D. Gluten and gliadin: precipitating factors in coeliac disease. Coeliac Disease 1996, 195-212. M. Maki, P. Collin, J.K. Visakorpi (Eds.).
20. Kupper C. Dietary guidelines and implementation for celiac disease. Gastroen- terology 2005, 128:121-127.
21. Lásztity R., Berndorfer-Kraszner E., Huszar M. On the presence and distribution of some bioactive agents in oat varieties. Cereals Food Beverages, Recent Prog. Cereal Chem.Technol., [Proc. Int. Conf] 1980, 429-445.
22. Leiss O. Pitfalls and problems of a gluten-free diet: Is oats harmful to patients with coeliac disease?. Aktuelle Ernahrungsmedizin 2003, 28:385-397. [In German].
23. Lindahl L., Ahldán I., Öste R., Sjöholm I. Homogenous and stable cereal suspension and a method of making the same. US Patent 5686123 1997.
24. Lundin K.E.A., Nilsen E.M., Scott H.G., Loberg E.M., Gjoen A., Bratlie J. Oats-induced villous atrophy in celiac disease. Gut 2003, 52:1649-1652.
25. Lyly M., Salmenkallio-Marttila M., Suortti T., Autio K., Poutanen K., Lähteenmäki L. The sensory characteristics and rheological properties of soups containing oat and barley β-glucan before and after freezing. Lebensm. Wiss. Technol. 2004, 37:749-761.
26. Mikola M. Natural oat bran instant drink. Proceedings of the 7th International Oat Conference, Jokioinen, MTT Agrifood Research, Finland 2004, 99. P. Peltonen-Sainio, M. Topi-Hulmi (Eds.).
27. Moulton A.L.C. The place of oats in the coeliac diet. Arch. Dis. Child. 1959, 34:51-55.
28. Önning G., Åkesson B., Öste R., Lundquist L. Effects of consumption of oat milk, soya milk, or cow's milk on plasma lipids and antioxidative capacity in healthy subjects. Ann. Nutr. Metab. 1998, 42:211-220.
29. Osman A.A., Uhlig H.H., Valdes I., Amin M., Mández E., Mothes T. A monoclonal antibody that recognizes a potential celiac-toxic repetitive pentapeptide epitope in gliadins. Eur. J. Gastroenterol. Hepatol. 2001, 13:1-5.
30. Peräaho M., Collin P., Kauhnen K., Kekkonen L., Miettinen S., Maki M. Oats can diversify a gluten-free diet in coeliac disease and dermatitis herpetiformis. J. Am. Diet. Assoc. 2004, 104:1148-1150.
31. Peräaho M., Kaukinen K., Mustalahti N. Effects of an oats-containing gluten-free diet on symptoms and quality of life in celiac disease. Scand. J. Gastroenterol. 2004, 39:27-31.
32. Peterson D.M., Qureshi A.A. Genotype and environment effects on tocols in barley and oats. Cereal Chem. 1993, 70:157-162.
33. Reunala T., Collin P., Holm K. Tolerance to oats in dermatitis herpetiformis. Gut 1998, 43:490-493.
34. Shewry P.R., Tatham A.S. The characteristics, structures and evolutionary relationships of prolamins. Seed Proteins 1999, 11-33. Kluwer Academic Publishers, Dordrecht. P.R. Shewry, R. Casey (Eds.).
35. Sorell L., López J.A., Valdás I. An innovative sandwich ELISA system based on an antibody cocktail for gluten analysis. FEBS Lett. 1998, 439:46-50.
36. Srinivasan U., Leonard N., Jones E., Kasarda D.D., Weir D.G., O'Farrelly C. Absence of oats toxicity in adult celiac disease. BMJ 1996, 313:1300-1301.
37. Störsrud S., Olsson M., Arvidsson L.R., Nilsson L., Nilsson O., Kilander A. Adult coeliac disease patients do tolerate large amounts of oats. Eur. J. Clin. Nutr. 2003, 57:163-169.
38. Valdes I., Garcia E., Llorente M., Mendez E. Innovative approach to low-level gluten determination in foods using a novel sandwich enzyme-linked immunosorbent assay protocol. Eur. J. Gastroenterol. Hepatol. 2003, 15:465-474.
39. van de Kamer J.H., Weijers H.A., Dicke W.K. Coeliac disease. IV. An investigation into the injurious constituents of wheat in connection with their action on patients with celiac disease. Acta Paediatr. 1953, 42:223-231.
40. Wieser H. Comparative investigations of gluten proteins from different wheat species; I. Qualitative and quantitative compositions of gluten protein types. Eur. Food Res. Techn. 2000, 211:262-268.
41. Wood P.J. Oat β-glucan: Structure, location and properties. Oats: Chemistry and Technology 1986, 121-152. American Association of Cereal Chemists, St. Paul, MN. F.H. Webster (Ed.).